glp-1 pharmacology and Anesthesia: Considerations and Cautions for CRNAs Pharmacogenetics of Glucagon-like-peptide-1 receptor in

Some providers extend the time at lower doses if a patient experiences significant GI side effects, and that is perfectly reasonable

The recommendations suggest that the use of GLP-1 RAs is projected to be of high value in comparison to other classes of diabetes medications

This informative webinar highlights industry leaders from WCG and Kailera Therapeutics engaging in a discussion about the multifaceted challenges faced by sponsors and sites in bringing GLP-1 drugs to market

Two analyses were conducted using propensity-score matching for baseline covariates

He now specializes in evidence-based weight management, including GLP-1/GIP therapies (semaglutide & tirzepatide)